Abstract
Rabson–Mendenhall syndrome is an autosomal recessive disorder of insulin signalling caused by mutations in the insulin receptor gene. Affected patients are insensitive to exogenous insulin. Insulin-like growth factor I (IGF-I), whose receptor is similar to the one for insulin and is not impaired in this condition, is not always effective in these patients. To understand the reason for this failure, IGF-I concentrations were measured in a patient after subcutaneous injection of 0.1 and 0.2 mg/kg of rhIGF-I. IGF-I concentrations increased only transiently because of the short half-life (1.3–3 h, compared to a normal range of 17–22 h). No correlation was found between IGF-I concentrations and glucose or insulin concentrations. The short half-life of IGF-I may contribute to treatment failure in patients with inherited insulin-resistant syndromes.
Similar content being viewed by others
REFERENCES
Backeljauw PF, Alves C, Eidson M, Cleveland W, Underwood LE, Davenport ML (1994) Effect of intravenous IGF-I in two patients with leprechaunism. Pediatr Res 36: 749-754.
Grahnen A, Kastrup K, Heinrich U, et al (1993) Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency. Acta Paediatr (Suppl) 82(supplement 391): 9-13.
Kuzuya H, Matsuura N, Sakamoto M, et al (1993) Trial of IGF-I therapy for patients with extreme insulin resistance syndromes. Diabetes 42: 696-705.
LeRoith D, Butler AA (1999) Insulin-like growth factors in pediatric health and disease. J Clin Endocrinol Metab 84: 4355-4361.
Longo N, Singh R, Griffin LD, Langley SD, Parks JS, Elsas LJ (1994) Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and IGF-I. J Clin Endocrinol Metab 79: 799-805.
Longo N, Wang Y, Pasquali M (1999) Progressive decline in insulin levels in Rabson-Mendenhall syndrome. J Clin Endocrinol Metab 84: 2623-2629.
Nakae J, Kato M, Murashita M, Shinohara N, Tajima T, Fujieda K (1998) Long-term effect of recombinant human IGF-I on metabolic and growth control in a patient with leprechaunism. J Clin Endocrinol Metab 83: 542-549.
Psiachou H, Mitton S, Alaghaband-Zadeh J, Hone J, Taylor SI, Sinclair L (1993) Leprechaunism and homozygous nonsense mutation in the insulin receptor gene. Lancet 342: 924.
Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC (1990) Acute response to recombinant IGF-I in a patient with Mendenhall's syndrome. N Engl J Med 323: 1425-1426.
Schoenle EJ, Zenobi PD, Torresani T, Wender EA, Zachmann M, Froesch ER (1991) rhIGF-I reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 34: 675-679.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Longo, N., Singh, R. & Elsas, L.J. Decreased half-life of insulin-like growth factor I in Rabson–Mendenhall syndrome. J Inherit Metab Dis 24, 546–550 (2001). https://doi.org/10.1023/A:1012411709972
Issue Date:
DOI: https://doi.org/10.1023/A:1012411709972